Richard Chin
Neurology · Montgomery, ALNPI 1558501460
Payments from drug & device makers
Across 516 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$2K
- AbbVie$958
- Boston Scientific$908
- Biohaven Pharmaceuticals, Inc.$543
- Teva Pharmaceuticals USA, Inc.$493
- Jazz Pharmaceuticals Inc.$422
- plus $4K from 31 others
What the payments were for
- Speaking & faculty fees$140%
- Food & beverage$8,525100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 81 | $1,566 |
| AbbVie(2 entities) | 71 | $958 |
| Boston Scientific | 87 | $908 |
| Biohaven Pharmaceuticals, Inc. | 31 | $543 |
| Teva Pharmaceuticals USA, Inc. | 26 | $493 |
| Jazz Pharmaceuticals Inc. | 23 | $422 |
| UCB, Inc. | 22 | $370 |
| SK Life Science, Inc. | 15 | $268 |
| Lilly USA, LLC | 10 | $242 |
| Novartis | 14 | $240 |
| Genentech USA, Inc. | 15 | $238 |
| Upsher-smith Laboratories LLC | 13 | $218 |
| GSK | 2 | $207 |
| Biogen | 15 | $195 |
| Novo Nordisk | 1 | $125 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $123 |
| Johnson & Johnson | 9 | $120 |
| Tanabe Pharma America, Inc. | 4 | $120 |
| Bristol Myers Squibb | 7 | $112 |
| Argenx US, Inc. | 4 | $107 |
| Mallinckrodt Enterprises LLC | 1 | $101 |
| Harmony Biosciences LLC | 6 | $101 |
| Lundbeck LLC | 6 | $100 |
| EMD Serono, Inc. | 8 | $96 |
| Greenwich Biosciences, Inc. | 6 | $94 |
| Sunovion Pharmaceuticals Inc. | 7 | $78 |
| Supernus Pharmaceuticals, Inc. | 5 | $73 |
| AstraZeneca | 4 | $70 |
| Eisai Inc. | 5 | $69 |
| Neurocrine Biosciences, Inc. | 3 | $44 |
| Pfizer | 3 | $39 |
| CSL Behring | 1 | $24 |
| Catalyst Pharmaceuticals, Inc. | 1 | $24 |
| Impel Pharmaceuticals Inc. | 1 | $16 |
| Acorda Therapeutics, Inc | 1 | $14 |
| Grifols USA, LLC | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,539 in reported general payments places this provider in the 60th percentile of 255 neurology providers in Alabama.
Other neurology in Montgomery
- Emily RiserBirmingham$7.1M
- Christopher LagankeCullman$5.9M
- Louis NaborsBirmingham$3.2M
- Belinda Savage-EdwardsHuntsville$2.8M
- Khurram BashirBirmingham$2.8M
- David GeldmacherBirmingham$2.6M
- Victor SungBirmingham$2M
- Mina LobbousBirmingham$1.8M
- Diane CounceBirmingham$1.4M
- Judy WhiteFlorala$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.